News

Mutations in a gene called ATP10B may increase the risk of developing Parkinson’s disease, a study has found. When mutated, ATP10B is no longer able to provide instructions to make a functional protein that is necessary to transport a fatty substance — known…

An inflammatory pathway that plays a key role in the proper removal of faulty cells during brain development could open new avenues for studying or treating neurological diseases, including Parkinson’s. The study, “AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment,” was published in Nature. During…

Levels of two mitochondrial-related proteins, clusterin and VPS35, may accurately diagnose Parkinson’s disease using a single blood drop, findings from a new study suggest. The research also suggests that a translational approach — one that moves from cell lab work to patients — which also incorporates relevant protein…

The clinical symptoms experienced by people with Parkinson’s disease, like dyskinesia or postural instability, may help to distinguish and group patients whose ability to perform daily activities are more or less affected, a new study suggests. These findings were detailed in, “Can We Predict the…

Scientists have discovered a series of rare variants in genes that control the function of lysosomes — cell compartments responsible for digesting and recycling different types of molecules — that are associated with Parkinson’s disease. The findings were published in an article, “Rare Variants in…

The National Research Council (NRC) of Canada will conduct a final phase of preclinical testing of GB Sciences‘ cannabinoid-based formulations for Parkinson’s disease to determine their mechanisms of action. This final step in testing follows promising results in a fish model of the disease, in which these…

A probiotic strain of the bacteria Bacillus subtilis called PXN21 can prevent the buildup of the protein alpha-synuclein — one of the hallmarks of Parkinson’s disease — in the round worm C. elegans, researchers reports. This finding warrants further investigation to assess the therapeutic potential of dietary…

To heighten awareness of Parkinson’s disease (PD) and inspire patients and their families, Bial Pharmaceuticals has produced a short video to mark World Parkinson’s Day this Saturday, April 11. Called “Keep On Moving,” the production also seeks to destigmatize the neurodegenerative disease and show the diversity and accomplishments…

Therapy given over the phone can help to lessen symptoms of depression in people with Parkinson’s disease, a new study suggests. The study, “Telephone-based cognitive behavioral therapy for depression in Parkinson disease,” was published in Neurology. Although often thought of as a movement disorder, Parkinson’s non-motor…

Aspen Neuroscience has raised $70 million to advance the development of  Parkinson’s disease therapies using patients’ own cells. The products, ANPD001 and ANPD002, are the first-ever Parkinson’s treatments designed to use a patient’s own cells as a replacement to restore neuronal function and to modify disease progression.